These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21524253)

  • 1. Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug.
    Bourgault S; Chatenet D; Wurtz O; Doan ND; Leprince J; Vaudry H; Fournier A; Vaudry D
    Curr Pharm Des; 2011; 17(10):1002-24. PubMed ID: 21524253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACAP as a neuroprotective factor in ischemic neuronal injuries.
    Shioda S; Nakamachi T
    Peptides; 2015 Oct; 72():202-7. PubMed ID: 26275482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of PACAP in ischemia.
    Reglodi D; Vaczy A; Rubio-Beltran E; MaassenVanDenBrink A
    J Headache Pain; 2018 Mar; 19(1):19. PubMed ID: 29500688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide.
    Bourgault S; Vaudry D; Dejda A; Doan ND; Vaudry H; Fournier A
    Curr Med Chem; 2009; 16(33):4462-80. PubMed ID: 19835562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of PACAP in central and peripheral nerve injuries.
    Tamas A; Reglodi D; Farkas O; Kovesdi E; Pal J; Povlishock JT; Schwarcz A; Czeiter E; Szanto Z; Doczi T; Buki A; Bukovics P
    Int J Mol Sci; 2012; 13(7):8430-8448. PubMed ID: 22942712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic and retinoprotective functions of PACAP.
    Shioda S; Takenoya F; Wada N; Hirabayashi T; Seki T; Nakamachi T
    Anat Sci Int; 2016 Sep; 91(4):313-24. PubMed ID: 27324639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
    Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
    Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model.
    Lamine A; Létourneau M; Doan ND; Maucotel J; Couvineau A; Vaudry H; Chatenet D; Vaudry D; Fournier A
    Neuropharmacology; 2016 Sep; 108():440-50. PubMed ID: 26006268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases.
    Lee EH; Seo SR
    BMB Rep; 2014 Jul; 47(7):369-75. PubMed ID: 24856828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide.
    Somogyvári-Vigh A; Reglodi D
    Curr Pharm Des; 2004; 10(23):2861-89. PubMed ID: 15379674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
    Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
    Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide.
    Doan ND; Chatenet D; Létourneau M; Vaudry H; Vaudry D; Fournier A
    Biochim Biophys Acta; 2012 Apr; 1823(4):940-9. PubMed ID: 22343001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis.
    Seaborn T; Masmoudi-Kouli O; Fournier A; Vaudry H; Vaudry D
    Curr Pharm Des; 2011; 17(3):204-14. PubMed ID: 21348830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes.
    Shieh PC; Tsao CW; Li JS; Wu HT; Wen YJ; Kou DH; Cheng JT
    Neurosci Lett; 2008 Mar; 434(1):1-5. PubMed ID: 18313848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of pituitary adenylate cyclase activating polypeptide against neurotoxic agents.
    Reglodi D; Tamas A; Jungling A; Vaczy A; Rivnyak A; Fulop BD; Szabo E; Lubics A; Atlasz T
    Neurotoxicology; 2018 May; 66():185-194. PubMed ID: 29604313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery.
    Vaudry D; Falluel-Morel A; Bourgault S; Basille M; Burel D; Wurtz O; Fournier A; Chow BK; Hashimoto H; Galas L; Vaudry H
    Pharmacol Rev; 2009 Sep; 61(3):283-357. PubMed ID: 19805477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase-activating polypeptide promotes eccrine gland sweat secretion.
    Sasaki S; Watanabe J; Ohtaki H; Matsumoto M; Murai N; Nakamachi T; Hannibal J; Fahrenkrug J; Hashimoto H; Watanabe H; Sueki H; Honda K; Miyazaki A; Shioda S
    Br J Dermatol; 2017 Feb; 176(2):413-422. PubMed ID: 27453364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase-activating polypeptide against hydrogen peroxide-induced oxidative damages in cultured rat astrocytes.
    Douiri S; Bahdoudi S; Hamdi Y; Cubì R; Basille M; Fournier A; Vaudry H; Tonon MC; Amri M; Vaudry D; Masmoudi-Kouki O
    J Neurochem; 2016 Jun; 137(6):913-30. PubMed ID: 26991551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons.
    Takei N; Skoglösa Y; Lindholm D
    J Neurosci Res; 1998 Dec; 54(5):698-706. PubMed ID: 9843161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo.
    Reglodi D; Kiss P; Lubics A; Tamas A
    Curr Pharm Des; 2011; 17(10):962-72. PubMed ID: 21524257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.